EMOR (Healixa) Marketable Securities: $0.00 Mil (As of . 20)


What is Healixa Marketable Securities?

Healixa EMOR +17.19% Marketable Securities is $0.00 Mil as of . 20.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Healixa's Marketable Securities for the quarter that ended in . 20 was $0.00 Mil.

Healixa  (OTCPK:EMOR) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Healixa Marketable Securities Related Terms

Healixa Marketable Securities Historical Data

* Premium members only.

The historical data trend for Healixa's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healixa Marketable Securities Chart

Healixa Annual Data
Trend
Marketable Securities

Healixa Quarterly Data
Marketable Securities

Healixa Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
Healixa (EMOR) has a Marketable Securities of $0.00 Mil as of . 20. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Healixa and its competitors.
Is Healixa's Marketable Securities too high?
Healixa's current Marketable Securities is $0.00 Mil.
How does Healixa's Marketable Securities compare to competitors?
Healixa's Marketable Securities of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Healixa and its competitors. Healixa's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healixa stock overvalued right now?
Healixa (EMOR) has a current Marketable Securities of $0.00 Mil. The current Marketable Securities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Healixa (EMOR), the current Marketable Securities is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Healixa Business Description

Address 273 Knickerbocker Avenue, Bohemia, New York, NY, USA, 11716
Healixa Inc is a technology company focused on building and acquiring disruptive technologies in the health-tech, clean water harvesting, and green-tech industries. Its activities consist mainly of research and development, intellectual property development, engineering validation, pilot deployment, and early-stage commercialization of its technology platforms. The company also focuses on clean water through its Eternal Spring Deposition Water Harvesting technology and on water harvesting and thermal cooling technologies.